Rapport Therapeutics, Inc. Common Stock
$27.57
-2.00 (-6.76%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -34.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -47.5%
Own RAPP?
See how RAPP contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.